0001019056-20-000244.txt : 20200319 0001019056-20-000244.hdr.sgml : 20200319 20200319183507 ACCESSION NUMBER: 0001019056-20-000244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200218 FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Marvin L CENTRAL INDEX KEY: 0001493324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 20729781 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 white.xml X0306 4 2020-02-18 0 0001671584 Aptevo Therapeutics Inc. APVO 0001493324 White Marvin L 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 1 1 0 0 President and CEO Stock Option (right to buy) 0.498 2020-02-18 4 A 0 303200 0 A 2030-02-17 Common Stock 303200 303200 D The option vests in three approximately equal annual installments beginning on February 17, 2021. /s/ Carl A. Valenstein, attorney-in-fact 2020-03-19